Company Description
Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally.
The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.
The company also provides microbiological and analytical chemistry testing, as well as technical assistance, regulatory consulting, and advisory services.
It serves medical devices, pharmaceuticals, food safety, agricultural products, cancer treatment, and high-performance materials industries, as well as commercial, advanced, and specialty application industries.
The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020.
Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.
| Country | United States |
| IPO Date | Nov 20, 2020 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 3,000 |
| CEO | Michael B. Petras Jr. |
Contact Details
Address: 9100 South Hills Blvd, Suite 300 Broadview Heights, Ohio 44147 United States | |
| Phone | 440-262-1410 |
| Website | soterahealth.com |
Stock Details
| Ticker Symbol | SHC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $23.00 |
| CIK Code | 0001822479 |
| CUSIP Number | 83601L102 |
| ISIN Number | US83601L1026 |
| Employer ID | 47-3531161 |
| SIC Code | 8090 |
Key Executives
| Name | Position |
|---|---|
| Michael B. Petras Jr. | Chairman and Chief Executive Officer |
| Alexander Dimitrief | Senior Vice President, General Counsel and Secretary |
| Michael P. Rutz | President of Sterigenics |
| Jonathan M. Lyons | Senior Vice President and Chief Financial Officer |
| Robert G. Hauzie | Chief Information Officer |
| Kristin A. Gibbs | Chief Marketing Officer |
| William O. Lehmann Jr., J.D., M.B.A. | Senior Vice President of Strategy and Corporate Development |
| Sally R. Turner | Chief Human Resources Officer |
| Kathleen A. Hoffman | Senior Vice President of Global Environmental, Health and Safety |
| Joseph A. Shrawder | President of Nelson Labs |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 11, 2024 | ARS | Filing |
| Apr 11, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 11, 2024 | DEF 14A | Other definitive proxy statements |
| Mar 22, 2024 | PRE 14A | Other preliminary proxy statements |
| Mar 4, 2024 | 8-K | Current Report |
| Feb 29, 2024 | 424B7 | Filing |
| Feb 27, 2024 | 424B7 | Filing |
| Feb 27, 2024 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers |
| Feb 27, 2024 | 10-K | Annual Report |
| Feb 27, 2024 | 8-K | Current Report |